Prokidney (PROK) Interest Coverage Ratio (2021 - 2026)
Prokidney (PROK) posted quarterly Interest Coverage Ratio of 3.41 for Q1 2026, down 9.32% year-over-year from 3.77 in Q1 2025, and down 610.4% quarter-over-quarter from 0.67 in Q4 2025.
Prokidney (PROK) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Interest Coverage Ratio for 6 consecutive years, with 3.41 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 9.32% year-over-year to 3.41; the TTM figure through Mar 2026 stood at 5.65 (up 250.65% YoY), while the FY2025 annual figure was 3.84, up 58.79% from the prior year.
- Interest Coverage Ratio declined to 3.41 in Q1 2026 per PROK's latest filing, from 0.67 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.67 in Q4 2025 and bottomed at 15117.5 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 1265.37 across 5 years, with a median of 3.49 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 109411.74% — and 2025, when it jumped 125.53%.
- Prokidney's Interest Coverage Ratio stood at 15117.5 in 2022, then surged by 100.0% to 0.49 in 2023, then sank by 434.81% to 2.62 in 2024, then surged by 125.53% to 0.67 in 2025, then tumbled by 610.4% to 3.41 in 2026.
- Business Quant data shows PROK's Interest Coverage Ratio at 3.41 in Q1 2026, 0.67 in Q4 2025, and 24.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | -3.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.41 |
| Mar 31, 2026 | -3.41 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | -24.36 |
| Jun 30, 2025 | -3.42 |
| Mar 31, 2025 | -3.12 |
| Dec 31, 2024 | -2.62 |
| Sep 30, 2024 | -22.29 |
| Jun 30, 2024 | -3.49 |
| Mar 31, 2024 | -9.92 |
| Dec 31, 2023 | -0.49 |
| Sep 30, 2023 | -223.05 |
| Jun 30, 2023 | -2.34 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -15,117.50 |
| Sep 30, 2022 | -1,226.62 |
| Jun 30, 2022 | -121.99 |
| Mar 31, 2022 | -4,747.29 |
| Dec 31, 2021 | -13.80 |
| Sep 30, 2021 | -17,081.00 |